Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (39 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 07 Nov 2016 – 20 Aug 2026, limited by Nippon India ETF Nifty 50 BeES. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Nippon India ETF Nifty 50 BeES | Nifty 50 |
|---|---|---|
| 07 Nov 2016 | ₹100.00 | ₹100.00 |
| 01 Sep 2017 | ₹118.36 | ₹117.39 |
| 26 Jun 2018 | ₹128.99 | ₹126.74 |
| 19 Apr 2019 | ₹142.04 | ₹138.32 |
| 11 Feb 2020 | ₹147.88 | ₹142.50 |
| 05 Dec 2020 | ₹163.11 | ₹156.04 |
| 29 Sep 2021 | ₹219.90 | ₹208.44 |
| 23 Jul 2022 | ₹209.95 | ₹196.77 |
| 17 May 2023 | ₹229.81 | ₹213.98 |
| 10 Mar 2024 | ₹286.81 | ₹264.72 |
| 02 Jan 2025 | ₹311.28 | ₹284.67 |
| 26 Oct 2025 | ₹335.58 | ₹303.58 |
| 20 Aug 2026 | ₹318.43 | ₹285.18 |
| Metric | Nippon India · Direct NAV ₹276.31 Very High risk ★★★☆☆ | Category median Other ETFs · 39 funds |
|---|---|---|
| -2.24% | +4.79% | |
| +9.06% | +14.28% | |
| +9.30% | +9.47% | |
| — | +11.94% | |
| +12.57% | +11.34% | |
| +7.65% | — | |
| +14.21% | +14.30% | |
| +15.02% | +13.66% | |
| — | +12.79% | |
| Risk | ||
| 13.24% | 14.41% | |
| 0.19 | 0.45 | |
| 0.27 | 0.61 | |
| -38.37% | -26.81% | |
| Nifty 50 | — | |
| +1.12% | +1.75% | |
| 1.00 | 1.00 | |
| 102.7% | 105.3% | |
| 96.2% | 98.1% | |
| 0.04% | 0.29% | |
| ₹63,032Cr | ₹250.35Cr | |
| None | — | |
| None | — | |
| — | — | |
| — | — | |
| — | — | |
| Himanshu Mange | — | |
| 07 Nov 2016 | — | |
| 50 | — | |
| 52.7% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.